Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitOxyVit: Hyperbaric oxygen plus narrowband UVB for vitiligo
2025-524709-34-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxygen in Vitiligo, sponsored by Centre Hospitalier Universitaire de Nice. Planned start Mar 2026; status: authorised.
02
Drugs
oxygen
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2025-524709-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524709-34-00.